Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
CDDP + GSH group (treatment group): Received 100 mg/m cisplatin with an additional 3 g/m intravenous glutathione (n = 74)
Synergistic Peptides + Use: Ipamorelin MOTS-c Key Advantages: Targets fat metabolism without affecting blood sugar, cortisol, or growth hormone feedback loops
To model natural-like GH pulses and IGF-1 activation in vitro and in vivo GH-axis studies
Research has investigated the compound across GH-axis pharmacology, pulsatile-GH-release characterisation, and combined GHRH-plus-GHRP studies
doi:10.1016/S0021-9258(18)56879-4
US$ 27.87
US$ 27.13
US$ 24.39
US$ 23.23
US$ 21.99
US$ 23.38
US$ 22.34
39.9 in" loading="lazy"/>